Compare Fiverr International Ltd (FVRR) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fiverr International Ltd vs Repligen Corporation Common Stock — how do they compare? Fiverr International Ltd trades at $8.56 (market cap $309.18M), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B). The key difference: Repligen Corporation Common Stock is far larger — about 36× Fiverr International Ltd's market cap, and Repligen Corporation Common Stock is trading nearer its 52-week high, Fiverr International Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Fiverr International Ltd for 62 Days and Repligen Corporation Common Stock for 0 Days on average.
| FVRR | RGEN | |
|---|---|---|
Market Cap | $309.18M | $11.14B |
Volume | 481,205 | 1,259,263 |
Sector | Media | Health |
52-Week High | $23.60 | $194.57 |
52-Week Low | $8.47 | $102.87 |
Typical Hold Time | 62 Days | 0 Days |
Enterprise Value | $61.56M | $11.02B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Fiverr International (FVRR) trades at $8.55, down 0.81% with bearish technical signals despite attractive valuation metrics including a P/E of 10.62 and P/S of 0.75. Recent Q2 2026 earnings missed expectations with revenue declining 10% year-over-year as AI disruption pressures freelance demand. The company maintains strong gross margins of 82% but faces headwinds from accelerating AI adoption compressing lower-value freelance work.
While valuation appears compelling with consensus price target of $10.50 representing 23% upside, near-term risks from AI disruption and recent earnings misses warrant caution. Analyst sentiment leans neutral with 76% hold ratings, reflecting uncertainty around growth trajectory amid structural industry shifts. Cash flow trends show volatility with negative net cash flow projected for 2026.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fiverr International Ltd
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Writing and Translation, and Video and Animation among others.
Read more on FVRR →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
